119 related articles for article (PubMed ID: 8385953)
1. Comparison of DNA stemline and cell kinetics between primary breast cancer and its lymph node metastasis.
Chang DB; Yang PC; Chang KJ; Luh KT; Kuo SH
Anal Quant Cytol Histol; 1993 Feb; 15(1):32-8. PubMed ID: 8385953
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer.
Beerman H; Smit VT; Kluin PM; Bonsing BA; Hermans J; Cornelisse CJ
Cytometry; 1991; 12(2):147-54. PubMed ID: 1646701
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry and cytomorphology in primary resectable breast cancer.
Bedrossian CW; Raber M; Barlogie B
Anal Quant Cytol; 1981 Jun; 3(2):112-6. PubMed ID: 6266303
[TBL] [Abstract][Full Text] [Related]
5. Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry.
Lee AK; Wiley B; Dugan JM; Hamilton WH; Loda M; Heatley GJ; Cook L; Silverman ML
Pathol Res Pract; 1992 Jun; 188(4-5):428-32. PubMed ID: 1329051
[TBL] [Abstract][Full Text] [Related]
6. The relationship of estrogen receptor status to DNA ploidy in breast cancer.
Tsuchiya A; Nihei M; Ando Y; Suzuki S; Kimijima I; Abe R
Surg Today; 1992; 22(2):105-9. PubMed ID: 1498488
[TBL] [Abstract][Full Text] [Related]
7. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
9. Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement.
Cornelisse CJ; de Koning HR; Moolenaar AJ; van de Velde CJ; Ploem JS
Anal Quant Cytol; 1984 Mar; 6(1):9-18. PubMed ID: 6732072
[TBL] [Abstract][Full Text] [Related]
10. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility and comparison of quantitative DNA histogram features obtained with a scanning microdensitometer and a flow cytometer in breast cancers.
Uyterlinde AM; Smeulders AW; Baak JP
Anal Quant Cytol Histol; 1989 Oct; 11(5):353-60. PubMed ID: 2553035
[TBL] [Abstract][Full Text] [Related]
12. [Relation of steroid receptors, tumor ploidy, and cell proliferation in various histologic types of breast cancer].
Zubrikhina GN; Ermilova VD; Kuz'mina ZV; Bassalyk LS
Arkh Patol; 1989; 51(3):10-6. PubMed ID: 2545183
[TBL] [Abstract][Full Text] [Related]
13. [Nuclear DNA ploidy pattern and cytological atypia in aspiration cytology of breast cancer].
Okazaki A; Okazaki M; Okazaki Y; Minamida H; Asaishi K; Hirata K
Gan To Kagaku Ryoho; 1993 Apr; 20(6):812-5. PubMed ID: 8489291
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
16. [Assay of DNA content and estrogen receptor status in human breast cancer].
Chen GJ; Shao YF; Shan Y
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
[TBL] [Abstract][Full Text] [Related]
17. DNA stainability in aneuploid breast tumors: comparison of four DNA fluorochromes differing in binding properties.
Myc A; Traganos F; Lara J; Melamed MR; Darzynkiewicz Z
Cytometry; 1992; 13(4):389-94. PubMed ID: 1326430
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer.
Yildirim-Assaf S; Coumbos A; Hopfenmüller W; Foss HD; Stein H; Kühn W
J Clin Pathol; 2007 Jun; 60(6):649-55. PubMed ID: 17557867
[TBL] [Abstract][Full Text] [Related]
20. Ploidy and S-phase fractions (SPF) of primary breast cancers and their nodal metastases.
Hupperets PS; Schutte B; van Assche C; Schouten LJ; Jager J; de Jong J; Blijham GH
Breast Cancer Res Treat; 1994; 32(2):197-202. PubMed ID: 7865849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
